ICAR PEDIATRIC SUSP OTC
Generic Name and Formulations:
Iron (as carbonyl) 15mg/1.25mL; grape flavor; sugar- and alcohol-free.
Indications for ICAR PEDIATRIC SUSP:
Iron deficiency and iron deficiency anemia.
1 tab once daily.
Use Ped Susp. 15mg (of iron) once daily.
Folic acid may mask pernicious anemia. Monitor hemoglobin, hematocrit, reticulocyte count periodically. Elderly.
Inhibits tetracycline absorption. Aluminum- or magnesium-containing antacids inhibit iron absorption.
Nausea, abdominal discomfort and pain, constipation, diarrhea, masks occult bleeding, black stools.
Ped Susp—4oz (w. dosing syringe)
Neurology Advisor Articles
- Gender and Multiple Sclerosis: How It Influences Prognosis and Future Treatment
- Significant Variations in Epilepsy Surgical Strategy, Deficit Reporting Exist
- Thrombolysis With Tenecteplase Is as Safe as Alteplase in Stroke Mimics
- Loss of Function Variants in LRRK1 and LRRK2 Not Linked to Parkinson Disease
- Smoking Promotes Disease Progression in Multiple Sclerosis
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- ZTlido Patch for Post-Shingles Pain Launching Soon
- Managing Complications of Intrathecal Baclofen Therapy
- Deep Brain Stimulation Reduces Tremor Symptoms in Parkinson Disease
- FDA Issues Statement Addressing Safety Concerns Associated With Nuplazid
- Prevalence of Autoimmune Encephalitis in Herpes Simplex Encephalitis Explored